Invex Therapeutics
Research - Subiaco, Western Australia, Australia
Invex Therapeutics Employees
Invex Therapeutics Senior Management
Invex Therapeutics Details
Invex Therapeutics (ASX: IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Invex has trademarked its repurposed Exenatide as Presendin™.
Website:
http://www.invextherapeutics.com
Employees:
8
HQ:
Location:
Subiaco, Western Australia, Australia
Revenue:
Invex Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Fonts
Typekit
Tag Management
Google Tag Manager
Other
Microsoft Office 365